Alveolar-capillary Reserve After Exercise in Chronic Obstructive Pulmonary Disease (COPD) (COP-DTPA)
NCT ID: NCT06287476
Last Updated: 2025-12-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2024-05-06
2025-05-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Physical Exercise Training in Patients With Chronic Obstructive Pulmonary Disease
NCT02050945
COPD-EXA-REHAB. Early Pulmonary Rehabilitation of Patients With Acute Exacerbation of COPD
NCT02987439
Characteristics of People With Advanced Chronic Obstructive Pulmonary Disease (COPD) - A Multicenter Study
NCT04249388
Pulmonary Diffusing Capacity During Incremental Exercise in COPD
NCT06505902
Optimizing the Effect of COPD Rehabilitation
NCT00419289
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group
This arm consist of only healthy participants (age (+/- 3 years) and sex matched to the COPD group), which will undergo three study visits
Acute exercise bout on visit 2 and 3
1\) a 5-minute warm-up, 2) 4 minutes at 60% of the maximal workload (determined on Study Day 1), 3) 2 minutes active break at 15 watt, 4) 4 minutes at maximal workload.
COPD group
This arm consist of only COPD patients, which will undergo three study visits
Acute exercise bout on visit 2 and 3
1\) a 5-minute warm-up, 2) 4 minutes at 60% of the maximal workload (determined on Study Day 1), 3) 2 minutes active break at 15 watt, 4) 4 minutes at maximal workload.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acute exercise bout on visit 2 and 3
1\) a 5-minute warm-up, 2) 4 minutes at 60% of the maximal workload (determined on Study Day 1), 3) 2 minutes active break at 15 watt, 4) 4 minutes at maximal workload.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 45-80 years old
* COPD (GOLD stage I to III)
* Resting arterial oxygenation \> 90%
* Men and women
* 45-80 years old
* Non-smokers
* Normal lung function
* Same sex, age (± 3 years) as the COPD group
Exclusion Criteria
* Known heart failure
* Symptoms of illness, including fever, within 2 weeks prior to the study
* Pregnancy
* • Known renal or liver diseaseActive smoking (within 3 weeks)
* Known chronic lung disease
* Symptoms of ischemic heart disease
* Known heart failure
* Symptoms of illness, including fever, within 2 weeks prior to the study
* Pregnancy
* Known renal or liver disease
* Active smoking (within 3 weeks)
45 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rigshospitalet, Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ronan Berg
MD, DMSc, Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Center For Physical Activity Research, Rigshospitalet
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-23043870
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.